| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Gülgün Tezel | |
| P2860 | cites work | Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head | Q22306304 |
| Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo | Q27860578 | ||
| Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes | Q28204043 | ||
| Regeneration beyond the glial scar | Q28239915 | ||
| Retinal deimination in aging and disease | Q28242539 | ||
| The classical complement cascade mediates CNS synapse elimination | Q28261273 | ||
| Oxidative stress and the regulation of complement activation in human glaucoma | Q28577665 | ||
| Origin and physiological roles of inflammation | Q29614298 | ||
| The blood-brain barrier in health and chronic neurodegenerative disorders | Q29616411 | ||
| Microglial physiology: unique stimuli, specialized responses | Q29620417 | ||
| Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease | Q30480854 | ||
| Early glial responses after acute elevated intraocular pressure in rats | Q30884327 | ||
| Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. | Q31090647 | ||
| Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data | Q31141723 | ||
| Gene Microarray Analysis of Experimental Glaucomatous Retina from Cynomologous Monkey | Q33193313 | ||
| Müller cell response to laser-induced increase in intraocular pressure in rats | Q33203572 | ||
| Viscoelastic material properties of the peripapillary sclera in normal and early-glaucoma monkey eyes. | Q33211207 | ||
| Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma | Q33222315 | ||
| Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma | Q46579568 | ||
| Glaucoma: macrocosm to microcosm the Friedenwald lecture | Q46618750 | ||
| Comparative gene array analysis of TNF-alpha-induced MAPK and NF-kappaB signaling pathways between retinal ganglion cells and glial cells | Q46635068 | ||
| Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension | Q46694030 | ||
| Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma | Q46966279 | ||
| Human optic nerve fiber count and optic disc size | Q47412773 | ||
| Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure | Q47903438 | ||
| Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture | Q48357321 | ||
| Retinal glial cell responses and Fas/FasL activation in rats with chronic ocular hypertension | Q48395910 | ||
| Induction of HLA-DR expression in human lamina cribrosa astrocytes by cytokines and simulated ischemia. | Q49075907 | ||
| Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma. | Q53557356 | ||
| T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma. | Q53894467 | ||
| Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. | Q53911833 | ||
| Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. | Q53913933 | ||
| Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. | Q53926835 | ||
| Autoantibodies to small heat shock proteins in glaucoma. | Q53943140 | ||
| The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis | Q59087662 | ||
| Age-related changes in the extracellular matrix of the human optic nerve head | Q69498792 | ||
| The effect of age on normal human optic nerve fiber number and diameter | Q69950027 | ||
| Increased incidence of paraproteinemia and autoantibodies in patients with normal-pressure glaucoma | Q72395545 | ||
| Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells | Q73258549 | ||
| Chronology of optic nerve head and retinal responses to elevated intraocular pressure | Q73437263 | ||
| Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head | Q73553792 | ||
| An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma | Q74060582 | ||
| Cyclooxygenase-1 and cyclooxygenase-2 in the human optic nerve head | Q74087479 | ||
| Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma | Q74188653 | ||
| Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head | Q74280271 | ||
| Clinical and ocular histopathological findings in a patient with normal-pressure glaucoma | Q77141245 | ||
| Differential gene expression in astrocytes from human normal and glaucomatous optic nerve head analyzed by cDNA microarray | Q77840980 | ||
| Autoimmunity on alert: naturally occurring regulatory CD4(+)CD25(+) T cells as part of the evolutionary compromise between a 'need' and a 'risk' | Q78431151 | ||
| Prevalence of serum autoantibodies and paraproteins in patients with glaucoma | Q79314126 | ||
| Glaucoma | Q79692226 | ||
| Age-related changes in neuronal susceptibility to damage: comparison of the retinal ganglion cells of young and old mice before and after optic nerve crush | Q80108349 | ||
| Primary open-angle glaucoma | Q80122027 | ||
| Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor | Q80572007 | ||
| C-reactive protein levels in normal tension glaucoma | Q81181810 | ||
| Serum cytokine alteration is associated with optic neuropathy in human primary open angle glaucoma | Q84513704 | ||
| Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes | Q33234966 | ||
| Retinal synthesis and deposition of complement components induced by ocular hypertension. | Q33242506 | ||
| Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. | Q33265694 | ||
| Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens | Q33314556 | ||
| Gene expression and functional studies of the optic nerve head astrocyte transcriptome from normal African Americans and Caucasian Americans donors | Q33361962 | ||
| Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension | Q33372453 | ||
| Protein macroarray profiling of serum autoantibodies in pseudoexfoliation glaucoma. | Q33526950 | ||
| The role of microglia and macrophages in the pathophysiology of the CNS. | Q33643184 | ||
| Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy | Q33693569 | ||
| Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma | Q33693579 | ||
| Age-associated epigenetic modifications in human DNA increase its immunogenicity | Q33771976 | ||
| Human innate immunosenescence: causes and consequences for immunity in old age. | Q33796293 | ||
| Gene expression changes in areas of focal loss of retinal ganglion cells in the retina of DBA/2J mice | Q33845093 | ||
| The optic nerve head in glaucoma: role of astrocytes in tissue remodeling | Q33882462 | ||
| Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage | Q34057614 | ||
| Apoptosis of inflammatory cells in immune control of the nervous system: role of glia | Q34398617 | ||
| Control of glial immune function by neurons | Q34398649 | ||
| Microglial senescence: does the brain's immune system have an expiration date? | Q34550017 | ||
| Why is Wallerian degeneration in the CNS so slow? | Q34628851 | ||
| Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling | Q34702076 | ||
| Immunity to self and self-maintenance: a unified theory of brain pathologies | Q34760206 | ||
| Immunopotentiating heat shock proteins: negotiators between innate danger and control of autoimmunity | Q35053449 | ||
| Macrophages and microglia in central nervous system injury: are they helpful or harmful? | Q35101280 | ||
| TNF-alpha signaling in glaucomatous neurodegeneration | Q35147990 | ||
| Heat-shock proteins: immunity and autoimmunity | Q35353487 | ||
| New roles for astrocytes (stars at last). | Q35548553 | ||
| Glaucomatous optic neuropathy: when glia misbehave | Q35609009 | ||
| Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences | Q35677091 | ||
| The immune system and glaucoma | Q35691309 | ||
| 4-Hydroxynonenal, a product of oxidative stress, leads to an antioxidant response in optic nerve head astrocytes | Q35698825 | ||
| Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model | Q35945481 | ||
| Ocular autoimmunity: the price of privilege? | Q36593726 | ||
| RAGE on the Toll Road? | Q36648122 | ||
| From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma | Q36773528 | ||
| Phosphorylation-dependent interaction with 14-3-3 in the regulation of bad trafficking in retinal ganglion cells | Q36808374 | ||
| Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia | Q36808534 | ||
| Extracellular heat shock proteins in cell signaling and immunity | Q36989297 | ||
| Does the blood-brain barrier play a role in Glaucoma? | Q36999009 | ||
| Autoimmunity and glaucoma | Q37095751 | ||
| Epigenetics, aging, and autoimmunity | Q37146128 | ||
| Premise and prediction-how optic nerve head biomechanics underlies the susceptibility and clinical behavior of the aged optic nerve head | Q37190892 | ||
| Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand | Q37195253 | ||
| Increased isolevuglandin-modified proteins in glaucomatous astrocytes. | Q37213688 | ||
| Friend or foe? Resolving the impact of glial responses in glaucoma | Q37230041 | ||
| Privilege revisited: an evaluation of the eye's defence mechanisms | Q37319391 | ||
| Mitochondrial dysfunction and glaucoma | Q37395695 | ||
| Immunoregulation of retinal ganglion cell fate in glaucoma | Q37398167 | ||
| The role of stress factors during aging of the immune system. | Q37399372 | ||
| Involvement of ROS in BBB dysfunction | Q37400756 | ||
| The role of glia, mitochondria, and the immune system in glaucoma | Q37401610 | ||
| Telomere shortening and ageing of the immune system. | Q37406623 | ||
| T-cell immunosenescence: lessons learned from mouse models of aging | Q37525668 | ||
| Para-inflammation in the aging retina. | Q37533486 | ||
| The blood-brain barrier and immune function and dysfunction | Q37576216 | ||
| Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells. | Q39691028 | ||
| Glaucoma: changes in extracellular matrix in the optic nerve head | Q40769903 | ||
| The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells. | Q40880921 | ||
| The role of microglia in brain injury | Q40923996 | ||
| The normal human optic nerve. Axon count and axon diameter distribution | Q41223565 | ||
| The optic nerve head in glaucomatous optic neuropathy | Q41390007 | ||
| Retinal microglia differentially express phenotypic markers of antigen-presenting cells in vitro. | Q41705750 | ||
| T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition | Q41884301 | ||
| Astrocytes in glaucomatous optic neuropathy | Q42600591 | ||
| Systemic high-sensitivity C-reactive protein levels in normal-tension glaucoma and primary open-angle glaucoma. | Q42617395 | ||
| Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients | Q42627567 | ||
| The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. | Q42677806 | ||
| Mitochondria: Their role in ganglion cell death and survival in primary open angle glaucoma | Q43111984 | ||
| Tumor necrosis factor-alpha mediates the blood-brain barrier dysfunction induced by activated microglia in mouse brain microvascular endothelial cells | Q43179286 | ||
| Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. | Q43187402 | ||
| TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes | Q43657407 | ||
| Immunohistologic evidence for retinal glial cell changes in human glaucoma | Q43940019 | ||
| Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. | Q44119121 | ||
| Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma | Q44489818 | ||
| Caspase-independent component of retinal ganglion cell death, in vitro | Q45124551 | ||
| Complex antibody profile changes in an experimental autoimmune glaucoma animal model. | Q46003233 | ||
| Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria | Q46311555 | ||
| Oxidative injury to blood vessels and glia of the pre-laminar optic nerve head in human glaucoma | Q46414846 | ||
| Effect of glaucoma on the retinal glutamate/glutamine cycle activity | Q46471175 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 178-186 | |
| P577 | publication date | 2010-08-13 | |
| P1433 | published in | Experimental Eye Research | Q15754753 |
| P1476 | title | The immune response in glaucoma: a perspective on the roles of oxidative stress | |
| P478 | volume | 93 |
| Q33570764 | A decade of proteomics studies of glaucomatous neurodegeneration |
| Q36348165 | A mouse ocular explant model that enables the study of living optic nerve head events after acute and chronic intraocular pressure elevation: Focusing on retinal ganglion cell axons and mitochondria |
| Q36828359 | A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration |
| Q49744181 | Age-related changes in the response of retinal structure, function and blood flow to pressure modification in rats. |
| Q30662499 | An approach to predict the risk of glaucoma development by integrating different attribute data |
| Q36082780 | An astrocyte-specific proteomic approach to inflammatory responses in experimental rat glaucoma |
| Q52577506 | Annexins in Glaucoma. |
| Q36867011 | Antioxidant Treatment Limits Neuroinflammation in Experimental Glaucoma |
| Q38941639 | Application of multiplex immunoassay technology to investigations of ocular disease |
| Q92716024 | Associations between TLR4 Polymorphisms and Open Angle Glaucoma: A Meta-Analysis |
| Q91152883 | Blockade of microglial adenosine A2A receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells |
| Q37015439 | Changes in Retinal N-Acylethanolamines and their Oxylipin Derivatives During the Development of Visual Impairment in a Mouse Model for Glaucoma |
| Q26774852 | Current perspective of neuroprotection and glaucoma |
| Q64928522 | Dietary Antioxidants, Macular Pigment, and Glaucomatous Neurodegeneration: A Review of the Evidence. |
| Q33719355 | Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective. |
| Q41592935 | Early remodelling of the extracellular matrix proteins tenascin-C and phosphacan in retina and optic nerve of an experimental autoimmune glaucoma model |
| Q64079985 | Elevated Plasma Levels of Drebrin in Glaucoma Patients With Neurodegeneration |
| Q34603641 | Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina |
| Q97519130 | Exosomes derived from microglia exposed to elevated pressure amplify the neuroinflammatory response in retinal cells |
| Q26864408 | From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma |
| Q38966980 | Genetic and Biochemical Biomarkers in Canine Glaucoma. |
| Q37702027 | Glioprotection of Retinal Astrocytes After Intravitreal Administration of Memantine in the Mouse Optic Nerve Crush Model |
| Q41780299 | Good news-bad news: the Yin and Yang of immune privilege in the eye. |
| Q90206205 | Immune Mediated Degeneration and Possible Protection in Glaucoma |
| Q36487609 | Immune regulation toward immunomodulation for neuroprotection in glaucoma |
| Q92280079 | Immunomodulation as a Neuroprotective Strategy for Glaucoma Treatment |
| Q36467223 | Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma |
| Q38178092 | Metallothioneins (MTs) in the human eye: a perspective article on the zinc-MT redox cycle. |
| Q36530573 | Molecular biomarkers in glaucoma |
| Q35524470 | Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina |
| Q42328273 | Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection |
| Q34277319 | Novel role for the innate immune receptor Toll-like receptor 4 (TLR4) in the regulation of the Wnt signaling pathway and photoreceptor apoptosis |
| Q38031910 | Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential |
| Q47106263 | Oxidative Stress-Related Molecular Biomarker Candidates for Glaucoma |
| Q38088831 | Oxidative stress and potential applications of free radical scavengers in glaucoma. |
| Q36050618 | Proteomics Analysis of Molecular Risk Factors in the Ocular Hypertensive Human Retina |
| Q41044103 | Proteomics analyses of human optic nerve head astrocytes following biomechanical strain. |
| Q28537957 | ROS detoxification and proinflammatory cytokines are linked by p38 MAPK signaling in a model of mature astrocyte activation |
| Q35157723 | Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma |
| Q46328207 | Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy |
| Q55515767 | Real-Time Imaging of Retinal Ganglion Cell Apoptosis. |
| Q87041812 | Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model |
| Q34254620 | Retinal stem cells transplantation combined with copolymer-1 immunization reduces interferon-gamma levels in an experimental model of glaucoma |
| Q34582221 | Retinal transcriptome profiling at transcription start sites: a cap analysis of gene expression early after axonal injury. |
| Q34493810 | Status of systemic oxidative stresses in patients with primary open-angle glaucoma and pseudoexfoliation syndrome |
| Q34418826 | Steady-state levels of retinal 24S-hydroxycholesterol are maintained by glial cells intervention after elevation of intraocular pressure in the rat. |
| Q64079184 | T-Lymphocyte Subset Distribution and Activity in Patients With Glaucoma |
| Q39227370 | The D₁ dopamine receptor agonist, SKF83959, attenuates hydrogen peroxide-induced injury in RGC-5 cells involving the extracellular signal-regulated kinase/p38 pathways. |
| Q37709378 | The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: a retrospective case-control study |
| Q34364056 | The association of glutathione S-transferase GSTT1 and GSTM1 gene polymorphism with pseudoexfoliative glaucoma in a Pakistani population |
| Q38226119 | The complex role of neuroinflammation in glaucoma |
| Q88292790 | The effects of age on mitochondria, axonal transport, and axonal degeneration after chronic IOP elevation using a murine ocular explant model |
| Q39402838 | The role and therapeutic potential of melatonin in age-related ocular diseases. |
| Q28389739 | Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling |
| Q90441803 | Transcriptional profiling analysis predicts potential biomarkers for glaucoma: HGF, AKR1B10 and AKR1C3 |
| Q58258852 | Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients |
| Q88104982 | [Complement activation after induction of ocular hypertension in an animal model] |
Search more.